Havana, May 20 (Prensa Latina) President Miguel Díaz-Canel today described the creation of a joint venture between Cuba’s BCF SA, BioCubaFarma, and Genfarma Holdings as a milestone in business and economic-commercial relations between Cuba and Vietnam.
In his profile on the social network X, the head of state reaffirmed his country’s commitment to continue strengthening ties with that Asian nation.
Díaz-Canel, along with Vietnamese Deputy Minister of Health Do Xuan Tuyen, presided over the signing of the agreement establishing the high-tech association in the biotechnology and pharmaceutical sectors the day before.
The president praised the event as “fulfilling the expectations we have in the consensus we reached with the General Secretary of the Communist Party of Vietnam, To Lam, during his visit to Cuba last year,” the Cuban presidency reported.
He also stressed the importance of moving forward, in parallel, with regulatory measures and ensuring that no time is wasted in making medicines available to the Vietnamese people.
For his part, the Vietnamese Deputy Minister of Health described it as an honor to witness the signing of the agreement, just as the two nations celebrate 65 years of diplomatic relations in 2025.
He expressed his gratitude for the opportunity to meet with the Cuban President and acknowledged the significance of the discussions held since his arrival in Cuba, both with representatives of the Ministry of Public Health and Cecmed, the Regulatory Authority for Medicines, Equipment, and Medical Devices.
He noted that several opportunities for cooperation of utmost importance to Vietnam were identified during the talks.
In this regard, he mentioned the development and implementation of family medicine; the elimination of mother-to-child transmission of HIV/AIDS, which Cuba achieved in 2015; as well as the development of biotechnology in the manufacturing of medicines and other products in Vietnam.
The president of the BioCubaFarma Business Group, Mayda Mauri, explained that the joint venture’s essential mission will be the transfer of technologies for biological and pharmaceutical products from Cuba.
It will also promote research and development activities in Vietnam for biological products and high-tech medicines, he noted.
rc/evm
